Not applicableWithdrawnNCT00329017What this trial is testingProtocol for Postmenopausal Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD
Not applicableUnknownNCT05868252What this trial is testingMolecular Analysis of the Sloane ProjectWho this might be right forDCISLCISAtypical Ductal Hyperplasia+1 more King's College London 1,500
Not applicableEnded earlyNCT05755269What this trial is testingAdding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic WomenWho this might be right forBreast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+1 more Mayo Clinic 19
Not applicableWithdrawnNCT03868475What this trial is testingComparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast LesionsWho this might be right forBreast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Early research (Phase 1)Study completedNCT03323658What this trial is testingBexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerWho this might be right forBreast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00291135What this trial is testingProtocol for Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 42
Not applicableStudy completedNCT01052740What this trial is testingX-Ray Mammography Standard of Care ProtocolWho this might be right forBreast CancerInvasive CarcinomaIn Situ Carcinoma+2 more National Institutes of Health Clinical Center (CC) 108
Not applicableStudy completedNCT01166763What this trial is testingModulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DWho this might be right forBreast Cancer Carol Fabian, MD 30
Not applicableActive Not RecruitingNCT04496739What this trial is testingMaking Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)Who this might be right forAtypical Hyperplasia of the BreastLobular Breast Carcinoma In SituPleomorphic Lobular Breast Carcinoma In Situ SWOG Cancer Research Network 412
Not applicableStudy completedNCT00666731What this trial is testingBreast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast CancerWho this might be right forBreast CancerPrecancerous Condition University of Nebraska 4,945
Early research (Phase 1)Study completedNCT00637481What this trial is testingA Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00291694What this trial is testingProtocol for Women at Increased Risk of Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 72
Not applicableLooking for participantsNCT00291096What this trial is testingHigh Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerWho this might be right forBreast Cancer Carol Fabian, MD 3,000
Not applicableEnded earlyNCT03505372What this trial is testingRole of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal HyperplasiaWho this might be right forAtypical Ductal Hyperplasia Dana-Farber Cancer Institute 5
Not applicableStudy completedNCT00291109What this trial is testingAn Examination of Predictors of Indicators of Response to Letrozole 2.5 mgWho this might be right forBreast Cancer University of Kansas 40
Not applicableStudy completedNCT00620087What this trial is testingMolecular Breast Imaging in Women With Atypia and LCISWho this might be right forAtypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ Mayo Clinic 66
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772What this trial is testingTrial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upWho this might be right forCarcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more Andrea DeCensi 500
Testing effectiveness (Phase 2)Ended earlyNCT04570956What this trial is testingOral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskWho this might be right forBreast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more Mayo Clinic 65
Testing effectiveness (Phase 2)Looking for participantsNCT05941520What this trial is testingAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerWho this might be right forBreast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more National Cancer Institute (NCI) 80
Not applicableStudy completedNCT01874184What this trial is testingGroup-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more University of Washington 17